Extracellular Vesicles in Neuroblastoma: Role in Progression, Resistance to Therapy and Diagnostics

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Apr 25

PMID 38660306

Authors

Mayura R Dhamdhere

Vladimir S Spiegelman

Affiliations

Soon will be listed here.

Abstract

Neuroblastoma (NB) is the most common extracranial solid pediatric cancer, and is one of the leading causes of cancer-related deaths in children. Despite the current multi-modal treatment regimens, majority of patients with advanced-stage NBs develop therapeutic resistance and relapse, leading to poor disease outcomes. There is a large body of knowledge on pathophysiological role of small extracellular vesicles (EVs) in progression and metastasis of multiple cancer types, however, the importance of EVs in NB was until recently not well understood. Studies emerging in the last few years have demonstrated the involvement of EVs in various aspects of NB pathogenesis. In this review we summarize these recent findings and advances on the role EVs play in NB progression, such as tumor growth, metastasis and therapeutic resistance, that could be helpful for future investigations in NB EV research. We also discuss different strategies for therapeutic targeting of NB-EVs as well as utilization of NB-EVs as potential biomarkers.

Citing Articles

Unveiling Tumorigenesis Mechanisms and Drug Therapy in Neuroblastoma by Mass Spectrometry Based Proteomics.

Ren K, Wang Y, Zhang M, Tao T, Sun Z Children (Basel). 2024; 11(11).

PMID: 39594898 PMC: 11593200. DOI: 10.3390/children11111323.

References

Fritsch P, Kerbl R, Lackner H, Urban C . "Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening. Pediatr Blood Cancer. 2004; 43(6):679-82. DOI: 10.1002/pbc.20126. View

Strenger V, Kerbl R, Dornbusch H, Ladenstein R, Ambros P, Ambros I . Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer. 2006; 48(5):504-9. DOI: 10.1002/pbc.20888. View

Amorim C, Docasar C, Guimaraes-Bastos D, Frony A, Barja-Fidalgo C, Renovato-Martins M . Extracellular Vesicles Derived from MDA-MB-231 Cells Trigger Neutrophils to a Pro-Tumor Profile. Cells. 2022; 11(12). PMC: 9221190. DOI: 10.3390/cells11121875. View

Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M . Neuroblastoma. Jpn J Clin Oncol. 2018; 48(3):214-241. DOI: 10.1093/jjco/hyx176. View

Perakis S, Speicher M . Emerging concepts in liquid biopsies. BMC Med. 2017; 15(1):75. PMC: 5382440. DOI: 10.1186/s12916-017-0840-6. View

Thompson D, Vo K, London W, Fischer M, Ambros P, Nakagawara A . Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2015; 122(6):935-45. PMC: 4777644. DOI: 10.1002/cncr.29848. View

Chicard M, Boyault S, Colmet Daage L, Richer W, Gentien D, Pierron G . Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma. Clin Cancer Res. 2016; 22(22):5564-5573. DOI: 10.1158/1078-0432.CCR-16-0500. View

Dhamdhere M, Spiegelman D, Schneper L, Erbe A, Sondel P, Spiegelman V . Generation of Novel Immunocompetent Mouse Cell Lines to Model Experimental Metastasis of High-Risk Neuroblastoma. Cancers (Basel). 2023; 15(19). PMC: 10571844. DOI: 10.3390/cancers15194693. View

Trigg R, Shaw J, Turner S . Opportunities and challenges of circulating biomarkers in neuroblastoma. Open Biol. 2019; 9(5):190056. PMC: 6544987. DOI: 10.1098/rsob.190056. View

10.

Yang K, Zhang F, Luo B, Qu Z . CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway. Cancer Biol Ther. 2022; 23(1):404-416. PMC: 9225373. DOI: 10.1080/15384047.2022.2072164. View

11.

Lu Y, Han G, Zhang Y, Zhang L, Li Z, Wang Q . M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. Cell Commun Signal. 2023; 21(1):299. PMC: 10614338. DOI: 10.1186/s12964-022-00872-w. View

12.

Ali S, Toews K, Schwiebert S, Klaus A, Winkler A, Grunewald L . Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4 CAR T Cell Efficacy. Front Immunol. 2020; 11:531. PMC: 7137471. DOI: 10.3389/fimmu.2020.00531. View

13.

Liu S, Yin W, Lin Y, Huang S, Xue S, Sun G . Metastasis pattern and prognosis in children with neuroblastoma. World J Surg Oncol. 2023; 21(1):130. PMC: 10091559. DOI: 10.1186/s12957-023-03011-y. View

14.

Huang M, Weiss W . Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013; 3(10):a014415. PMC: 3784814. DOI: 10.1101/cshperspect.a014415. View

15.

Challagundla K, Wise P, Neviani P, Chava H, Murtadha M, Xu T . Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015; 107(7). PMC: 4651042. DOI: 10.1093/jnci/djv135. View

16.

Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

17.

Galardi A, Colletti M, Businaro P, Quintarelli C, Locatelli F, Di Giannatale A . MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential. Curr Med Chem. 2017; 25(5):584-600. DOI: 10.2174/0929867324666171003120335. View

18.

Basta N, Halliday G, Makin G, Birch J, Feltbower R, Bown N . Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. Br J Cancer. 2016; 115(9):1048-1057. PMC: 5117794. DOI: 10.1038/bjc.2016.302. View

19.

Bown N, Cotterill S, Lastowska M, ONeill S, Pearson A, Plantaz D . Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 1999; 340(25):1954-61. DOI: 10.1056/NEJM199906243402504. View

20.

Panachan J, Rojsirikulchai N, Pongsakul N, Khowawisetsut L, Pongphitcha P, Siriboonpiputtana T . Extracellular Vesicle-Based Method for Detecting Amplification Status of Pediatric Neuroblastoma. Cancers (Basel). 2022; 14(11). PMC: 9179557. DOI: 10.3390/cancers14112627. View